Inteliquet

Inteliquet is a leading provider of technology, insights and expertise for cancer clinical research. Our proprietary platform securely, accurately, and quickly aggregates and analyzes EMR and related healthcare data, helping to ensure clinical trials are designed more effectively, sites and patients are matched to trials more rapidly, and patient-care decisions are made using RWE.
OncWeb™ is Inteliquet’s platform that securely and more completely identifies eligible patients for trials. It enables a more accurate understanding of patient populations, better informs care decisions and helps identify and select the most appropriate sites for trials. Inteliquet focuses on adaptive technology that can keep pace with healthcare data’s ever-changing landscape, including AI-related technologies, such as Natural Language Processing (NLP) and sophisticated heuristic parsers to extract data from unstructured data. Inteliquet’s offerings truly are EMR- and data-source agnostic, setting them apart from other solutions.
Inteliquet’s Cancer Center Research Consortium partners with community-based and academic cancer centers to create a proprietary database of de-identified cancer patient health records. Inteliquet seamlessly integrates and supports their utilization of OncWeb,™ including applications designed specifically to help them efficiently and in reduced time select the best-fitting clinical trials and assist them with their patient recruitment efforts - ultimately freeing up their time to dedicate to patient care.
Inteliquet works with life sciences firms in support of their product development life cycle with services including: patient matching and study services, clinical, HEOR and RWE analytics and applied de-identified data and services.
Inteliquet is committed to ensuring every patient - regardless of race, geography, age, sex, economic status, or stage of disease - has access to promising therapies as soon as they become available.... More Info Less Info